Last edition
News about "Strides to market Incepta"
Strides to market Incepta's WHO-prequalified long-acting contraceptive in Africa
The product, branded as “Medogen SubQ”, is a three-monthly subcutaneous injectable version of depot medroxyprogesterone acetate (DMPA-SC) that can be administered by trained healthcare workers or self-injected after appropriate instruction.
Strides To Market Incepta | 21/10/2025 | By Darshana | 237
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members